Scarica l'app Stockscreener
4.83
3.87%
0.18
Dopo l'orario di chiusura:
4.80
-0.03
-0.62%
Onconetix Inc Borsa (ONCO) Ultime notizie
Onconetix Secures Nasdaq Listing with Panel Decision - TipRanks
Onconetix receives positive decision by Nasdaq Hearings Panel - TipRanks
Onconetix regains Nasdaq compliance after filing Q1 report - Investing.com
Onconetix, Inc. Announces Positive Decision By Nasdaq Hearings Panel - MarketScreener
Onconetix, Inc. Announces Positive Decision by Nasdaq Hearings Panel - GlobeNewswire
Onconetix Avoids Nasdaq Delisting: Key Panel Decision Keeps Biotech Stock Listed - Stock Titan
Onconetix, Inc. SEC 10-Q Report - TradingView
Onconetix to implement 1-for-85 reverse stock split effective June 13 By Investing.com - Investing.com South Africa
Onconetix Issues Promissory Note to Keystone Capital - TipRanks
Onconetix to implement 1-for-85 reverse stock split effective June 13 - Investing.com Nigeria
Onconetix Announces 1-For-85 Reverse Stock Split - marketscreener.com
Onconetix to Implement 1-for-85 Reverse Stock Split - marketscreener.com
Onconetix announces 1-for-85 reverse stock split - MSN
Onconetix, Inc. Announces Approval of 1-for-85 Reverse Stock Split by Stockholders - Nasdaq
Spotify Stock Soars 124% in a Year: Time to Buy, Hold or Fold? - The Globe and Mail
Onconetix, Inc. Announces 1-for-85 Reverse Stock Split and Results of the Special Meeting of Stockholders - GlobeNewswire
Onconetix, Inc. Announces 1-for-85 Reverse Stock Split and Results of the Special Meeting of ... - Bluefield Daily Telegraph
Onconetix Implements Massive 1:85 Reverse Split, Slashing Shares from 44M to 521K to Save Nasdaq Listing - Stock Titan
1 Monster Growth Stock That's Crushing the Market in 2025 - The Globe and Mail
Onconetix Stockholders Approve Reverse Stock Split Proposal - TipRanks
1 ETF to Buy Hand Over Fist to Follow the TACO Trade - The Globe and Mail
Tariffs Aren't O'Reilly's Biggest Problem, This Is - The Globe and Mail
Onconetix, Inc. Reports Earnings Results for the Full Year Ended December 31, 2024 - marketscreener.com
Onconetix, Inc. SEC 10-K Report - TradingView
Leading Industrial Manufacturer Selects HawkSearch to Power Digital Commerce Growth - The Globe and Mail
Onconetix receives additional delisting notice from Nasdaq - Yahoo Finance
Onconetix, Inc. Announces Receipt of Additional Notice from Nasdaq - The Manila Times
Onconetix faces potential Nasdaq delisting over filing delays By Investing.com - Investing.com Nigeria
Onconetix receives additional notice from Nasdaq - MSN
Onconetix Faces Nasdaq Delisting Notice Amid Compliance Issues - TipRanks
Onconetix faces potential Nasdaq delisting over filing delays - Investing.com Australia
Onconetix, Inc. Receives Nasdaq Delisting Letter for Failure to File Quarterly Report and Maintain Minimum Bid Price Requirements - Nasdaq
Onconetix Faces Triple Threat: Nasdaq Delisting Risk Over Missing Filings and 10-Cent Stock Price - Stock Titan
Noram Receives Results for CVZ-66: High of 1540 ppm Intersection of 220ft (67.1 m) Averaging 1124 ppm of Lithium - The Globe and Mail
ONCOOnconetix Latest Stock News & Market Updates - Stock Titan
Correction: Onconetix Announces Financing Through a $2.0 Million Private Placement of Series C Preferred Stock and Warrants, Establishes a $25 Million Equity Line of Credit - Barchart.com
Critical Alert: Onconetix Hit With Second Nasdaq Delisting Notice as Deadline Looms - Stock Titan
Onconetix Inc [ONCO] Is Currently 14.45 above its 200 Period Moving Avg: What Does This Mean? - dbtnews.com
Onconetix Inc (ONCO) expanding its growth trajectory ahead - Sete News
ONCO Stock on the Rise: A Promising Investment - investchronicle.com
This morning’s top pick is Onconetix Inc (NASDAQ:ONCO) - uspostnews.com
Take off with Onconetix Inc (ONCO): Get ready for trading - Sete News
ONCO’s Stock Market Pendulum: Swinging Between Gains and Losses - investchronicle.com
Form 424B3Prospectus [Rule 424(b)(3)] - ADVFN
Form 8-KCurrent report - ADVFN
Onconetix faces third delisting threat since 2022 IPOCincinnati Business Courier - The Business Journals
Onconetix faces Nasdaq delisting over low share price By Investing.com - Investing.com India
Onconetix faces Nasdaq delisting over low share price - Investing.com
ONCO’s current quarter earnings: What analysts forecast? - uspostnews.com
ONCO stock plunges to 52-week low, touches $0.06 - Investing.com Australia
ONCO stock plunges to 52-week low, touches $0.06 By Investing.com - Investing.com South Africa
Cincinnati's Onconetix pursuing merger deal with drug development firm - The Business Journals
Onconetix Sets Stage For Potential Business Combination With Ocuvex Therapeutics - marketscreener.com
Onconetix, Ocuvex Therapeutics Sign Letter of Intent for Potential Merger; Shares Up Pre-Bell - marketscreener.com
1.11%
1.70%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):